S. Sinclair

Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1.

N. Leonard, S. Leech, P. Barrett, 2001, Journal of clinical pathology.

Community oncologists’ perceptions and utilization of large-panel genomic tumor testing

Karen E. Rasmussen, J. Roberts, M. Hall, 2021, BMC Cancer.

The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl

S. Steinberg, S. Hewitt, S. Swain, 2016, Breast Cancer Research and Treatment.

Primary systemic chemotherapy for inflammatory breast cancer

S. Swain, S. Sinclair, 2010, Cancer.